The forecast period is expected to witness a steady revenue Compound Annual Growth Rate (CAGR) in the global Fungal Pneumonia Treatment Market. The growth in revenue is primarily driven by the increasing incidence of pneumonia and the rise in the prevalence of community-acquired pneumonia, particularly among the younger population.
https://www.reportsanddata.com..../report-detail/funga